Association of Anti–Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma

Authors :: Kristin K. Ancell
Anna K. Dewan
Fei Ye
Henry T. Quach
Elizabeth J. Davis
Douglas B. Johnson
Run Fan
Source :: JAMA Oncology. 5:906
Publication Year :: 2019
Publisher :: American Medical Association (AMA), 2019.
Abstract: This cohort study of patients with advanced melanoma treated with anti–programmed cell death 1 with or without ipilimumab assessed whether cutaneous toxic effects were associated with superior clinical outcomes.

Tools